The combination of thrombocytosis and JAK2/MPL/CALR mutations is highly suggestive for undiagnosed MPN or a premalignant condition, while other gene mutations seem to have no relevance in these cases. This evidence concerns the gene JAK2 and thrombocytosis disease.